Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 3 Trial

Recent news which mentions Phase 3 Trial

< Previous 1 2 3 4 5 6 7 8 Next >
Zai Lab's Niraparib Shows 3X Longer PFS Compared to Placebo In Ovarian Cancer
Tickers ZLAB
Tags News Briefs Benzinga
From Benzinga
Why Are Allena Pharma Shares Plunging Today
Tickers ALNA
Tags News Health Care Trading Ideas
From Benzinga
Merck Lays Out Keytruda Data In Post Surgery Early-Stage Lung Cancer Setting
Tickers MRK
Tags MRK General Market News
From Benzinga
FDA Issues Corrected Advice To InflaRx's Vilobelimab Study In Skin Disease
Tickers IFRX
Tags IFRX Market News Penny Stocks
From Benzinga
Why Eiger BioPharmaceuticals Stock Is Jumping Today
Tickers BMY EIGR
Tags General Movers Biotech
From Benzinga
Eli Lilly's Phase 3 Jardiance Study Stopped Early Due To Clear Positive Efficacy In Kidney Disease
Tickers LLY
Tags Briefs News Biotech
From Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
Tickers BIIB
Tags BIIB General Market News
From Benzinga
Apellis' Pegcetacoplan Showed Continuous, Meaningful Effects At Month 18 In Geographic Atrophy Studies
Tickers APLS
Tags Market News APLS News
From Benzinga
Astellas' Menopause Drug Suffers Setback After Failed Asian Trial
Tickers ALPMF ALPMY
Tags Benzinga Health Care Phase 3 Trial
From Benzinga
Junshi Biosciences - Coherus Toripalimab Chemo Combo Met Survival Endpoints In Lung Cancer Setting
Tickers CHRS
Tags Non/Small Cell Lung Cancer Briefs Movers
From Benzinga
Merck-AstraZeneca Stop Keytruda/Lynparza Combo Trial In Prostate Cancer Patients
Tickers AZN AZNCF MRK
Tags Market News MRK prostate cancer
From Benzinga
AbbVie's Migraine Treatment Drug Touts Encouraging Data In Preventive Treatment Setting
Tickers ABBV
Tags Briefs Migraines Biotech
From Benzinga
Read Why Valneva's Stock Gained 7% Today
Tickers VALN
Tags Chikungunya Briefs Biotech
From Benzinga
Can-Fite BioPharma Flags Delay In Piclidenoson Data Readout From Psoriasis Study
Tickers AMGN CANF
Tags Psoriasis Market News CANF
From Benzinga
Gilead Sciences' Trodelvy Study In Breast Cancer Meets Primary Endpoint
Tickers GILD
Tags General GILD breast cancer
From Benzinga
Optinose's XHANCE Meets Primary Endpoints In Chronic Sinusitis Trial
Tickers OPTN
Tags General Phase 3 Trial Benzinga
From Benzinga
Merck's Keytruda Shows Improved Metastasis-Free Survival In Melanoma Patients
Tickers MRK
Tags General Biotech Benzinga
From Benzinga
NIH Discontinues COVID-19 Phase 3 Trial Assessing SAB Biotherapeutics' SAB-185
Tickers SABS
Tags Market News General Phase 3 Trial
From Benzinga
See Why Did Finch Therapeutics Halt Enrolment In Late-Stage C. Difficile Infection Trial
Tickers FNCH
Tags Market News Health Care Trading Ideas
From Benzinga
Pfizer's Clostridioides Difficile Vaccine Fails To Prevent C. Difficile Infection
Tickers PFE
Tags Market News General Benzinga
From Benzinga
Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial
Tickers KRTX
Tags Market News Health Care Earnings
From Benzinga
Marinus Pharma Delays Status Epilepticus, IV Ganaxolone Clinical Trials Into 2023
Tickers MRNS
Tags Market News News Trading Ideas
From Benzinga
AstraZeneca's Enhertu Meets Primary Endpoint In HER2-Low Breast Cancer Setting
Tickers AZN AZNCF DSKYF DSNKY
Tags Briefs Biotech Movers
From Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
Tickers ANY NVS REGN RHHBF
Tags Health Care SNY ANY
From Benzinga
Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study
Tickers BIIB SAGE
Tags General Briefs Phase 3 Trial
From Benzinga
ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting
Tickers ENDP IBRX MRK
Tags Phase 2 Trial Small Cap General
From Benzinga
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
Tickers BMY EXEL
Tags renal cell carcinoma Market News General
From Benzinga
Aveo Says Tivozanib Patients Up To 5X More Likely To Experience Long-Term PFS Vs. Nexavar In Kidney Cancer
Tickers AVEO BAYRY
Tags Phase 3 Trial Benzinga Biotech
From Benzinga
Data Committee Recommends Veru's COVID-19 Trial To Continue Unmodified
Tickers VERU
Tags Market News COVID/19 Coronavirus Health Care
From Benzinga
Biohaven/Pfizer Partnered Rimegepant Asia-Pacific Migraine Trial Meets Primary Endpoints
Tickers BHVN PFE
Tags migraine General Phase 3 Trial
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.